MYOCARDIAL INTERSTITIUM: FROM HISTOPHYSIOLOGY TO CARDIOSCLEROSIS AND ECTOPIC CALCIFICATION

Authors

DOI:

https://doi.org/10.32345/USMYJ.3(164).2026.102-113

Keywords:

myocardial stroma, telocytes, fibroblasts, extracellular matrix, cardiosclerosis, ectopic calcification

Abstract

Introduction. A fundamental paradigm shift has occurred in modern cardiology: the myocardial interstitium (stroma) is no longer considered a passive scaffold, but a highly dynamic, metabolically active neuro-immune-vascular niche that maintains structural homeostasis, regulates electrophysiology and contractility, and determines the trajectory of pathological cardiac remodeling.

Aim. To systematize current data on the structural and cellular organization of the myocardial stroma and to characterize the mechanisms of crosstalk between stromal elements and cardiomyocytes underlying fibrosis and ectopic calcification.

Materials and Methods. A systematic review of PubMed/MEDLINE, Scopus, and Web of Science was performed; 48 of over 200 identified sources (2005–2026), predominantly from Q1-Q2 journals, were selected for analysis.

Results. The myocardial architecture possesses a laminar spatial organization formed by collagen fibers of the endomysium and perimysium. The cellular composition of the interstitium is highly heterogeneous. Telocytes form a three-dimensional scaffold via telopodes, physically integrating tissue structures while stimulating cardiomyocyte maturation and maintaining regenerative potential through microRNA secretion. Pericytes control capillary blood flow — their pathological spasm underlies the “no-reflow” phenomenon during ischemia — and orchestrate regeneration through a secretome that stimulates neoangiogenesis and limits fibrosis. Cardiac fibroblasts govern matrix biosynthesis; their stepwise activation into myofibroblasts and matrifibrocytes drives replacement or reactive fibrosis, and fibroblast-derived TGF-β directly suppresses cardiomyocyte contractility. Beyond fibrosis, disrupted collagen turnover and ectopic stromal calcification (e.g., due to Fetuin-A deficiency) produce myocardial stiffness and diastolic dysfunction (HFpEF) refractory to pharmacological treatment.

Conclusions. The physiological and pathological state of the heart depends entirely on bidirectional crosstalk between cardiomyocytes and the stroma; future cardiological and regenerative therapies must target the integrated multi-tissue microenvironment rather than the isolated cardiomyocyte.

References

1. Picchio, V., Bordin, A., Floris, E., Cozzolino, C., Dhori, X., Peruzzi, M., Frati, G., De Falco, E., Pagano, F., & Chimenti, I. (2022). The dynamic facets of the cardiac stroma: from classical markers to omics and translational perspectives. American journal of translational research, 14(2), 1172-1187. https://pmc.ncbi.nlm.nih.gov/articles/PMC8902528/

2. Avolio, E., Alvino, V. V., Ghorbel, M. T., & Campagnolo, P. (2017). Perivascular cells and tissue engineering: Current applications and untapped potential. Pharmacology & therapeutics, 171, 83–92. https://doi.org/10.1016/j.pharmthera.2016.11.002

3. Bowers, S. L. K., Meng, Q., & Molkentin, J. D. (2022). Fibroblasts orchestrate cellular crosstalk in the heart through the ECM. Nature cardiovascular research, 1(4), 312–321. https://doi.org/10.1038/s44161-022-00043-7

4. Fountoulaki, K., Dagres, N., & Iliodromitis, E. K. (2015). Cellular Communications in the Heart. Cardiac failure review, 1(2), 64–68. https://doi.org/10.15420/cfr.2015.1.2.64

5. Katerina Fountoulaki, Nikolaos Dagres, Efstathios K Iliodromitis, Cellular Communications in the Heart, Cardiac Failure Review 2015;1(2):64–8 https://doi.org/10.15420/cfr.2015.1.2.64

6. Kleefeldt, F., Michelbach, P., Rueckschloss, U., Ergün, S., & Wagner, N. (2025). Three-Dimensional Visualization of the Cardiac Stroma. Cells, 14(14), 1119. https://doi.org/10.3390/cells14141119

7. Colliva, A., Braga, L., Giacca, M., & Zacchigna, S. (2020). Endothelial cell-cardiomyocyte crosstalk in heart development and disease. The Journal of physiology, 598(14), 2923–2939. https://doi.org/10.1113/JP276758

8. Colliva, A., Braga, L., Giacca, M., & Zacchigna, S. (2020). Endothelial cell-cardiomyocyte crosstalk in heart development and disease. The Journal of physiology, 598(14), 2923–2939. https://doi.org/10.1113/JP276758

9. Zhang, P., Su, J., & Mende, U. (2012). Cross talk between cardiac myocytes and fibroblasts: from multiscale investigative approaches to mechanisms and functional consequences. American journal of physiology. Heart and circulatory physiology, 303(12), H1385–H1396. https://doi.org/10.1152/ajpheart.01167.2011

10. Tan, S., Yang, J., Hu, S., & Lei, W. (2024). Cell-cell interactions in the heart: advanced cardiac models and omics technologies. Stem cell research & therapy, 15(1), 362. https://doi.org/10.1186/s13287-024-03982-z

11. Pope, A. J., Sands, G. B., Smaill, B. H., & LeGrice, I. J. (2008). Three-dimensional transmural organization of perimysial collagen in the heart. American journal of physiology. Heart and circulatory physiology, 295(3), H1243–H1252. https://doi.org/10.1152/ajpheart.00484.2008

12. Wang, S., Wang, Y., Li, Z., Zhao, Y., Zhang, Y., & Varray, F. (2024). Investigating the three-dimensional myocardial micro-architecture in the laminar structure using X-ray phase-contrast microtomography. Scientific reports, 14(1), 14329. https://doi.org/10.1038/s41598-024-65371-z

13. Kleefeldt, F., Michelbach, P., Rueckschloss, U., Ergün, S., & Wagner, N. (2025). Three-Dimensional Visualization of the Cardiac Stroma. Cells, 14(14), 1119. https://doi.org/10.3390/cells14141119

14. Wagner, N., & Wagner, K.-D. (2023). Molecular Mechanisms of Cardiac Development and Disease. International Journal of Molecular Sciences, 24(10), 8784. https://doi.org/10.3390/ijms24108784

15. Segers VFM, Brutsaert DL and De Keulenaer GW (2018) Cardiac Remodeling: Endothelial Cells Have More to Say Than Just NO. Front. Physiol. 9:382. doi: 10.3389/fphys.2018.00382

16. Winegrad, S., Henrion, D., Rappaport, L., & Samuel, J. L. (1998). Vascular endothelial cell-cardiac myocyte crosstalk in achieving a balance between energy supply and energy use. Advances in experimental medicine and biology, 453, 507–514. https://doi.org/10.1007/978-1-4684-6039-1_56

17. Allbritton-King JD and García-Cardeña G (2023) Endothelial cell dysfunction in cardiac disease: driver or consequence?. Front. Cell Dev. Biol. 11:1278166. doi: 10.3389/fcell.2023.1278166

18. Leucker, T. M., Bienengraeber, M., Muravyeva, M., Baotic, I., Weihrauch, D., Brzezinska, A. K., Warltier, D. C., Kersten, J. R., & Pratt, P. F., Jr (2011). Endothelial-cardiomyocyte crosstalk enhances pharmacological cardioprotection. Journal of molecular and cellular cardiology, 51(5), 803–811. https://doi.org/10.1016/j.yjmcc.2011.06.026

19. Leucker, T. M., Bienengraeber, M., Muravyeva, M., Baotic, I., Weihrauch, D., Brzezinska, A. K., Warltier, D. C., Kersten, J. R., & Pratt, P. F., Jr (2011). Endothelial-cardiomyocyte crosstalk enhances pharmacological cardioprotection. Journal of molecular and cellular cardiology, 51(5), 803–811. https://doi.org/10.1016/j.yjmcc.2011.06.026

20. Su, H., Cantrell, A. C., Zeng, H., Zhu, S. H., & Chen, J. X. (2021). Emerging Role of Pericytes and Their Secretome in the Heart. Cells, 10(3), 548. https://doi.org/10.3390/cells10030548

21. Dalkara, T., Østergaard, L., Heusch, G., & Attwell, D. (2025). Pericytes in the brain and heart: functional roles and response to ischaemia and reperfusion. Cardiovascular research, 120(18), 2336–2348. https://doi.org/10.1093/cvr/cvae147

22. Su, H., Cantrell, A. C., Zeng, H., Zhu, S. H., & Chen, J. X. (2021). Emerging Role of Pericytes and Their Secretome in the Heart. Cells, 10(3), 548. https://doi.org/10.3390/cells10030548

23. Gaceb, A., & Paul, G. (2018). Pericyte Secretome. Advances in experimental medicine and biology, 1109, 139–163. https://doi.org/10.1007/978-3-030-02601-1_11

24. Kreutziger, K. L., Muskheli, V., Johnson, P., Braun, K., Wight, T. N., & Murry, C. E. (2011). Developing vasculature and stroma in engineered human myocardium. Tissue engineering. Part A, 17(9-10), 1219–1228. https://doi.org/10.1089/ten.TEA.2010.0557

25. Goodwill, A. G., Dick, G. M., Kiel, A. M., & Tune, J. D. (2017). Regulation of Coronary Blood Flow. Comprehensive Physiology, 7(2), 321–382. https://doi.org/10.1002/cphy.c160016

26. Whittaker, O. R., Lynes, M. D., Pinz, I., & Liaw, L. (2025). Promotion of Cardiovascular Homeostasis by the Perivascular Adipose Tissue Secretome. International journal of molecular sciences, 26(20), 10173. https://doi.org/10.3390/ijms262010173

27. Itzhaki, I., Schiller, J., Beyar, R., Satin, J., & Gepstein, L. (2006). Calcium handling in embryonic stem cell-derived cardiac myocytes: of mice and men. Annals of the New York Academy of Sciences, 1080, 207–215. https://doi.org/10.1196/annals.1380.017

28. Bani, D., Formigli, L., Gherghiceanu, M., & Faussone-Pellegrini, M. S. (2010). Telocytes as supporting cells for myocardial tissue organization in developing and adult heart. Journal of cellular and molecular medicine, 14(10), 2531–2538. https://doi.org/10.1111/j.1582-4934.2010.01119.x

29. Bani D. (2016). Telocytes in Cardiac Tissue Architecture and Development. Advances in experimental medicine and biology, 913, 127–137. https://doi.org/10.1007/978-981-10-1061-3_8

30. Liskova, Y. V., Stadnikov, A. A., & Salikova, S. P. (2018). Kardiologiia, 58(Suppl 8), 29–37.

31. Van Wagoner D. R. (2024). Collagen type V, interstitial fibrosis and the substrate for atrial fibrillation. International journal of cardiology. Heart & vasculature, 50, 101356. https://doi.org/10.1016/j.ijcha.2024.101356

32. Cadosch, N., Gil-Cruz, C., Perez-Shibayama, C., & Ludewig, B. (2024). Cardiac Fibroblastic Niches in Homeostasis and Inflammation. Circulation research, 134(12), 1703–1717. https://doi.org/10.1161/CIRCRESAHA.124.323892

33. Torimoto, K., Elliott, K., Nakayama, Y., Yanagisawa, H., & Eguchi, S. (2024). Cardiac and perivascular myofibroblasts, matrifibrocytes, and immune fibrocytes in hypertension; commonalities and differences with other cardiovascular diseases. Cardiovascular research, 120(6), 567–580. https://doi.org/10.1093/cvr/cvae044

34. Kong, P., Christia, P., & Frangogiannis, N. G. (2014). The pathogenesis of cardiac fibrosis. Cellular and molecular life sciences : CMLS, 71(4), 549–574. https://doi.org/10.1007/s00018-013-1349-6

35. Piątek-Matuszak, P., Pasławski, R., Pasławska, U., Kiczak, L., Płóciennik, M., Janiszewski, A., Michałek, M., Gwizdała, A., Kaźmierczak, J., & Gorący, J. (2022). Assessment of Myocardial Diastolic Dysfunction as a Result of Myocardial Infarction and Extracellular Matrix Regulation Disorders in the Context of Mesenchymal Stem Cell Therapy. Journal of clinical medicine, 11(18), 5430. https://doi.org/10.3390/jcm11185430

36. Cartledge, J. E., Kane, C., Dias, P., Tesfom, M., Clarke, L., Mckee, B., Al Ayoubi, S., Chester, A., Yacoub, M. H., Camelliti, P., & Terracciano, C. M. (2015). Functional crosstalk between cardiac fibroblasts and adult cardiomyocytes by soluble mediators. Cardiovascular research, 105(3), 260–270. https://doi.org/10.1093/cvr/cvu264

37. Hoagland, D. T., Santos, W., Poelzing, S., & Gourdie, R. G. (2019). The role of the gap junction perinexus in cardiac conduction: Potential as a novel anti-arrhythmic drug target. Progress in biophysics and molecular biology, 144, 41–50. https://doi.org/10.1016/j.pbiomolbio.2018.08.003

38. Jæger, K. H., Louch, W. E., & Tveito, A. (2025). Reduced gap junction coupling amplifies the effects of cardiomyocyte variability and destabilizes the heartbeat. Physiological reports, 13(13), e70461. https://doi.org/10.14814/phy2.70461

39. Thompson, S. A., Copeland, C. R., Reich, D. H., & Tung, L. (2011). Mechanical coupling between myofibroblasts and cardiomyocytes slows electric conduction in fibrotic cell monolayers. Circulation, 123(19), 2083–2093. https://doi.org/10.1161/CIRCULATIONAHA.110.015057

40. Hegyi, B., Shimkunas, R., Jian, Z., Izu, L. T., Bers, D. M., & Chen-Izu, Y. (2021). Mechanoelectric coupling and arrhythmogenesis in cardiomyocytes contracting under mechanical afterload in a 3D viscoelastic hydrogel. Proceedings of the National Academy of Sciences of the United States of America, 118(31), e2108484118. https://doi.org/10.1073/pnas.2108484118

41. Hegyi, B., Shimkunas, R., Jian, Z., Izu, L. T., Bers, D. M., & Chen-Izu, Y. (2021). Mechanoelectric coupling and arrhythmogenesis in cardiomyocytes contracting under mechanical afterload in a 3D viscoelastic hydrogel. Proceedings of the National Academy of Sciences of the United States of America, 118(31), e2108484118. https://doi.org/10.1073/pnas.2108484118

42. Saffitz J. E. (2005). Dependence of electrical coupling on mechanical coupling in cardiac myocytes: insights gained from cardiomyopathies caused by defects in cell-cell connections. Annals of the New York Academy of Sciences, 1047, 336–344. https://doi.org/10.1196/annals.1341.030

43. Dogacan Yucel, Michael A. Trembley, Qingen Ke, Zexuan Wu, Peter Kang, William T. Pu bioRxiv (2025). Molecular Mechanisms of Cardiomyocyte Aging doi: https://doi.org/10.1101/2025.07.29.666777

44. Jeong, E. M., & Dudley, S. C., Jr (2015). Diastolic dysfunction. Circulation journal : official journal of the Japanese Circulation Society, 79(3), 470–477. https://doi.org/10.1253/circj.CJ-15-0064

45. Saheera, S., & Krishnamurthy, P. (2020). Cardiovascular Changes Associated with Hypertensive Heart Disease and Aging. Cell transplantation, 29, 963689720920830. https://doi.org/10.1177/0963689720920830

46. Horn, M. A., & Trafford, A. W. (2016). Aging and the cardiac collagen matrix: Novel mediators of fibrotic remodelling. Journal of molecular and cellular cardiology, 93, 175–185. https://doi.org/10.1016/j.yjmcc.2015.11.005

47. Lai, Y. H., Lo, C. I., Wu, Y. J., Hung, C. L., & Yeh, H. I. (2013). Cardiac Remodeling, Adaptations and Associated Myocardial Mechanics in Hypertensive Heart Diseases. Acta Cardiologica Sinica, 29(1), 64–70.

48. Merx, M. W., Schäfer, C., Westenfeld, R., Brandenburg, V., Hidajat, S., Weber, C., Ketteler, M., & Jahnen-Dechent, W. (2005). Myocardial stiffness, cardiac remodeling, and diastolic dysfunction in calcification-prone fetuin-A-deficient mice. Journal of the American Society of Nephrology : JASN, 16(11), 3357–3364. https://doi.org/10.1681/ASN.2005040365

Downloads

Published

2026-09-16

How to Cite

1.
Oleksandr M. Grabovyi, Anna Y. Kondaurova. MYOCARDIAL INTERSTITIUM: FROM HISTOPHYSIOLOGY TO CARDIOSCLEROSIS AND ECTOPIC CALCIFICATION. USMYJ [Internet]. 2026 Sep. 16 [cited 2026 Sep. 17];164(3):102-13. Available from: https://mmj.nmuofficial.com/index.php/journal/article/view/682